References
- Khondkarian OA, Burak AI, Skobelsky MD. [On the condition of chromosome complex in patients with disseminated sclerosis], in Russian. Vest Akad Med Nauk 1967;22:85–8.
- Housset E, Emerit I, Baulon A, de Grouchy YJ. Anomalies chromosomiques dans la sclérodermie: etude de 10 malades. Cr Acad Sci Paris 1969;296:413–16.
- Wolff DJ, Needleman BW, Wasserman SS, Schwartz S. Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991;18:837–40.
- Pan SF, Rodnan GP, Deutsch M, Wald N. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Med 1975;86:300–8.
- Migliore L, Bevilacqua C, Scarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients. Mutagenesis 1999;14:227–31.
- Porciello G, Scarpato R, Ferri C, Storino F, Cagetti F, Morozzi G, Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud’s phenomenon. J Rheumatol 2003;30:1244–7.
- Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369–74.
- Masi AT; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
- Clements PJ, Lachenbruch PA, Siebold J, White B, Weiner S, Martin R, Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281–5.
- Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;285:35–44.
- Tan FK, Hildebrand BA, Lester MS, Stivers DN, Pounds S, Zhou X, Classification analysis of the transcriptosome of non-affected cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 2005;52:865–76.
- Fuzii HT, Yoshikawa GT, Junta CM, Sandrin-Garcia P, Fachin AL, Sakamoto-Hojo ET, Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals. Clin Exp Rheumatol 2008;26:866–74.
- Herrick AL, Cerinic MM. The emerging problem of oxidative stress and the role of anti-oxidants in systemic sclerosis. Clin Exp Rheumatol 2001;19:4–8.
- Fontenelle SMA, Kayser C, Pucinelli MLC, Andrade LEC. Cold stimulus fingertip lacticemy test: an effective method to monitor acute therapeutic intervention on primary Raynaud’s phenomenon and systemic sclerosis. Rheumatology 2008;47:80–3.
- Wipff J, Dieude P, Avouac J, Tiev K, Hachulla E, Granel B, Diot E, Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population. Scand J Rheumatol 2009;38:291–4.
- Emerit I, Filipe P, Meunier P, Auclair C, Freitas J, Deroussent A, Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress. Dermatology 1997;194:140–6.
- Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G. Oxidative stress in scleroderma. Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001;44:2653–64.
- Caspary WJ, Niziak C, Lanzo DA, Friedman R, Bachur NR. Bleomycin A2: a ferrous oxidase. Mol Pharmacol 1979;16:256–60.